Orthofix Medical Inc. (OFIX) Stock Forecast
OFIX analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 5 analysts
- Price target
- $13.00 average of analyst targets
- Upside to target
- +38.6% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $-0.31
- 52-week range
- $8.64 – $16.23
OFIX analyst ratings
5 analystsNumber of analysts at each rating.
OFIX price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
OFIX earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.11 | $0.11 | $0.11 | $0.20 | −44.3% | 1 |
| Current fiscal year (2026) | $0.41 | $0.41 | $0.41 | $0.49 | −15.9% | 1 |
| Next fiscal year (2027) | $0.37 | $0.37 | $0.37 | $0.41 | −9.8% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
OFIX revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $210.5M | $210.0M | $210.8M | +2.4% | 4 |
| Current fiscal year (2026) | $851.2M | $849.6M | $852.4M | +3.5% | 4 |
| Next fiscal year (2027) | $873.7M | $862.5M | $881.0M | +2.6% | 4 |
OFIX EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
OFIX revenue: reported and forecast
OFIX EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.08 | $0.11 | $0.11 | $0.11 | $0.11 | +37.5% | 1 up · 0 down |
| Current fiscal year (2026) | $0.30 | $0.41 | $0.41 | $0.41 | $0.41 | +36.7% | 1 up · 0 down |
| Next fiscal year (2027) | $0.84 | $0.37 | $0.37 | $0.37 | $0.37 | −56.0% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
OFIX earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; OFIX beat in 12 of 12.
What analysts expect from OFIX
5 analysts cover Orthofix Medical; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $13.00, 38.6% above the latest close of $9.38. Analysts expect earnings of $0.41 per share for 2026, −15.9% from a year earlier. For 2027 the average estimate is $0.37 per share on revenue of $873.7 million. Orthofix Medical beat the EPS estimate in 12 of the last 12 quarters.
Related: OFIX income statement, OFIX key metrics, OFIX chart. See the OFIX stock overview for the latest quote and news.
OFIX forecast FAQ
What is Orthofix Medical's price target?
The average analyst price target for Orthofix Medical is $13.00, 38.6% above the latest close of $9.38.
Is Orthofix Medical a buy, hold or sell?
Of 5 analysts covering Orthofix Medical, 2 rate it a strong buy, 1 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Orthofix Medical's EPS forecast?
Analysts forecast $0.41 per share for 2026 (range $0.41 to $0.41); for 2027 the estimate is $0.37.
What is Orthofix Medical's revenue forecast?
The average revenue estimate for 2026 is $851.2 million, growth of 3.5%; for 2027 it is $873.7 million.
When does Orthofix Medical report earnings?
Orthofix Medical is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 before the market opens; the EPS estimate is $-0.31.
Does Orthofix Medical usually beat earnings estimates?
Orthofix Medical reported EPS at or above the analyst estimate in 12 of the last 12 quarters.